Abstract:Targeted anticancer drugs block cancer cell growth by interfering with specific signaling pathways vital to carcinogenesis and tumor growth rather than harming all rapidly dividing cells as in cytotoxic chemotherapy. The Response Evaluation Criteria in Solid Tumor (RECIST) system has been used to assess tumor response to therapy via changes in the size of target lesions as measured by calipers, conventional anatomically based imaging modalities such as computed tomography (CT), and magnetic resonance imaging (MRI), and other imaging methods. However, RECIST is sometimes inaccurate in assessing the efficacy of targeted therapy drugs because of the poor correlation between tumor size and treatment-induced tumor necrosis or shrinkage. This approach might also result in delayed identification of response when the therapy does confer a reduction in tumor size. Innovative molecular imaging techniques have rapidly gained importance in the dawning era of targeted therapy as they can visualize, characterize, and quantify biological processes at the cellular, subcellular, or even molecular level rather than at the anatomical level. This review summarizes different targeted cell signaling pathways, various molecular imaging techniques, and developed probes. Moreover, the application of molecular imaging for evaluating treatment response and related clinical outcome is also systematically outlined. In the future, more attention should be paid to promoting the clinical translation of molecular imaging in evaluating the sensitivity to targeted therapy with biocompatible probes. In particular, multimodal imaging technologies incorporating advanced artificial intelligence should be developed to comprehensively and accurately assess cancer-targeted therapy, in addition to RECIST-based methods.

Molecular Targeted Therapy of Cancer: the Progress and Future Prospect

Research Progress in the Mechanism of Molecular Targeted Anti-tumor Drugs

Molecular-targeted Therapy for Cancer

Research advances of targeted therapy of cancer

Role of Small Molecule Targeted Compounds in Cancer: Progress, Opportunities, and Challenges

Advances on Resistance of Molecular Targeted Anti-tumor Drugs

Molecularly targeted cancer therapy: some lessons from the past decade

Advances in Molecularly Targeted Cancer Therapy

The multi-molecular mechanisms of tumor-targeted drug resistance in precision medicine

Molecular Target Therapy: a Milestone on the Road for Curing Cancer

Targeted Therapy: Resistance and Re-Sensitization

Molecular targeted therapy for anticancer treatment

Molecular targeted therapy: Treating cancer with specificity

Small molecules in targeted cancer therapy: advances, challenges, and future perspectives

Molecular-targeted therapy of pancreatic carcinoma and its progress

Advances on Molecular Targeted Anti-Tumor Drugs

Molecular targeted therapy for metastatic colorectal cancer: current and evolving approaches

Molecular perspective on targeted therapy in breast cancer: a review of current status

Molecular and functional imaging in cancer-targeted therapy: current applications and future directions

Translational medicine promising personalized therapy in oncology

Progress of Molecular Targeted Therapies for Prostate Cancers